In the latest trading session, 0.42 million Guardant Health Inc (NASDAQ:GH) shares changed hands as the company’s beta touched 1.41. With the company’s most recent per share price at $42.97 changing hands around $1.19 or 2.84% at last look, the market valuation stands at $5.30B. GH’s current price is a discount, trading about -18.43% off its 52-week high of $50.89. The share price had its 52-week low at $15.81, which suggests the last value was 63.21% up since then. When we look at Guardant Health Inc’s average trading volume, we note the 10-day average is 1.53 million shares, with the 3-month average coming to 2.33 million.
Analysts gave the Guardant Health Inc (GH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.48. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended GH as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight. Guardant Health Inc’s EPS for the current quarter is expected to be -0.58.
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH is in green as seen in intraday trades today. With action 1.17%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 40.64%, with the 5-day performance at 1.17% in the green. However, in the 30-day time frame, Guardant Health Inc (NASDAQ:GH) is 19.88% up. Looking at the short shares, we see there were 8.35 million shares sold at short interest cover period of 3.18 days.
The consensus price target for the stock as assigned by Wall Street analysts is 52, meaning bulls need an upside of 17.37% from its recent market value. According to analyst projections, GH’s forecast low is 52 with 52 as the target high. To hit the forecast high, the stock’s price needs a -21.01% plunge from its current level, while the stock would need to soar -21.01% for it to hit the projected low.
Guardant Health Inc (GH) estimates and forecasts
Year-over-year growth is forecast to reach 15.84% up from the last financial year.
Consensus estimates given by 18 financial analysts project the company’s revenue in the current quarter to hit an average of 189.91M. 18 analysts are of the opinion that Guardant Health Inc’s revenue for the current quarter will be 205.61M. The company’s revenue for the corresponding quarters a year ago was 168.49M and 177.24M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 12.71%. The estimates for the next quarter sales put growth at 16.01%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -33.61%. The 2025 estimates are for Guardant Health Inc earnings to increase by 19.03%, but the outlook for the next 5-year period is at 17.52% per year.
Guardant Health Inc (NASDAQ:GH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.78% of Guardant Health Inc shares while 98.69% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 103.64%. There are 98.69% institutions holding the Guardant Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.5609% of the shares, roughly 11.64 million GH shares worth $336.07 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 9.1777% or 11.24 million shares worth $324.55 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 3.63 shares estimated at $153.65 million under it, the former controlled 2.94% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.46% of the shares, roughly 3.04 shares worth around $128.48 million.
